Pembrolizumab

FDA Keytruda

Sep 4, 2014Melanoma, Lung Cancer, Non-Small Cell, Unresectable or Metastatic Melanoma, nsclc, squamous nsclc, Classical Hodgkin Lymphoma, Head and Neck Squamous Cell Cancer, Malignant Pleural Mesothelioma, Primary Mediastinal Large B Cell Lymphoma, hnscc

EMA Keytruda

Jul 17, 2015Melanoma, Hodgkin Disease, Carcinoma, Renal Cell, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Squamous Cell Carcinoma of Head and Neck, Urologic Neoplasms, Endometrial Neoplasms, Advanced Melanoma, Stage III Melanoma, non squamous non small cell lung carcinoma, Advanced Renal Cell Carcinoma, Biliary Cancer, Biliary Tract Carcinoma, Cervical Cancer, Classical Hodgkin Lymphoma, Colorectal Cancer, DMMR Colorectal Cancer, Endometrial Carcinoma, Head and Neck Squamous Cell Carcinoma, Locally Advanced Cervical Cancer, Locally Advanced Head and Neck Squamous Cell Carcinoma, Malignant Pleural Mesothelioma, Metastatic Colorectal Cancer, Metastatic Non-Small Cell Lung Carcinoma, Metastatic Non-Squamous Non-Small Cell Lung Carcinoma, Metastatic Squamous Non-Small Cell Lung Carcinoma, Metastatic Triple Negative Breast Cancer, Metastatic Urothelial Carcinoma, Mismatch Repair Deficient Colorectal Cancer, Oesophageal Carcinoma, Ovarian Cancer, Persistent, Recurrent, or Metastatic Cervical Cancer, Primary Peritoneal Carcinoma, Recurrent Endometrial Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma, Triple -Negative Breast Cancer, Urothelial Carcinoma, resectable muscle-invasive bladder cancer, locally advanced or metastatic urothelial carcinoma, recurrent or metastatic head and neck squamous cell carcinoma

Tumor

Phase 4Recruiting157 trials

Hepatocellular carcinoma

Phase 3Results posted59 trials

Multiple myeloma

Phase 3Terminated18 trials

Glioblastoma

Phase 3Active, not recruiting31 trials

Solid tumor

Phase 4Recruiting24 trials

Hematologic neoplasms

Phase 3Recruiting2 trials

Autosomal Dominant Lewy Body Parkinson Disease 4

Phase 4Results posted162 trials

Ureteral Neoplasms

Phase 4Recruiting11 trials

Triple negative breast neoplasm

Phase 3Results posted135 trials

Prostatic neoplasm

Phase 3Results posted39 trials

Fallopian tube neoplasm

Phase 3Results posted30 trials

Adenocarcinoma Of Esophagus

Phase 3Completed18 trials

NCT03407170TerminatedAdvanced melanoma

Lack of Accrual

NCT04738487TerminatedLung neoplasm

Business Reasons

NCT03019588TerminatedStomach neoplasm

Business Reasons

NCT05092360TerminatedOvarian neoplasm

Study terminated due to business and strategic decision.

NCT04246177TerminatedHepatocellular carcinoma

Business Reasons

NCT04777851TerminatedHepatocellular carcinoma

The trial ended earlier than planned due to slow enrolment, which has made it unfeasible to achieve the target sample size within a reasonable timeframe. Consequently, a business decision has been made to discontinue funding for the trial.